NCT07542379 2026-04-21
The Safety, Dosimetry and Efficacy of 177Lu-FC516 in Patients With Prostate Cancer
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
8 trialsNCT07516704 2026-04-08
Safety and Efficacy of Docetaxel, Darolutamide, and Homoharringtonine Combined With Androgen Deprivation Therapy in Neoadjuvant Treatment of High-Risk Prostate Cancer: A Multicenter Prospective, Single-Arm Clinical Study
Zhongda Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07439120 2026-02-27
Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1 Not yet recruiting
NCT07389174 2026-02-05
Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Shanghai Changzheng Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07381582 2026-02-02
161Tb-LNC1011
Peking Union Medical College Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07240857 2025-11-21
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
Zhejiang University
Phase EARLY_PHASE1 Not yet recruiting
NCT06708936 2025-09-03
KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study
Kousai Bio Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06546527 2024-08-09
Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC）
Peking University First Hospital
Phase EARLY_PHASE1 Not yet recruiting